Skip to main content
. 2020 Apr 26;21(9):3054. doi: 10.3390/ijms21093054

Table 2.

Diagnostic approach to ICI-related PM/DM.

Any Grade
Neurological and rheumatological anamnesis, rheumatological (inspection of the skin to identify signs suggestive of dermatomyositis) and neurological (muscle strength determination) objective examinations
Blood chemistry tests including:
  • CPK, transaminases (AST, ALT), LDH, aldolase

  • Cardiac enzymes (to identify possible concomitant myocarditis)

  • Markers of inflammation (ESR, CRP)

  • Consider searching for anti-AChR antibodies (to identify possible concomitant MG) and for antibodies causing neurological syndromes and paraneoplastic myositis

Consider a neurophysiological examination (needle EMG, neuromuscular plaque determination to identify possible concomitant MG, or a nerve conduction study to identify possible concomitant neuropathy)
Consider muscle MRI or tissue biopsy if the diagnosis is uncertain
CPK, ESR and CRP for follow-up
Grade 2
In addition to the above:
Rapid rheumatological or neurological evaluation
Grade 3
In addition to the above:
Urgent rheumatological or neurological evaluation

ICI, immune checkpoint inhibitor; PM/DM, polymyositis/dermatomyositis; CPK, creatine phosphokinase; AST, aspartate aminotransferase; ALT, alanine aminotransferase; LDH, Lactate dehydrogenase; ESR, erythrocyte sedimentation rate; CRP, C-reactive protein; AChR, acetylcholine receptor; MG, myasthenia gravis; MRI, magnetic resonance imaging.